5-chloromethylfluorescein diacetate has been researched along with thioctic acid in 1 studies
| Studies (5-chloromethylfluorescein diacetate) | Trials (5-chloromethylfluorescein diacetate) | Recent Studies (post-2010) (5-chloromethylfluorescein diacetate) | Studies (thioctic acid) | Trials (thioctic acid) | Recent Studies (post-2010) (thioctic acid) |
|---|---|---|---|---|---|
| 107 | 0 | 38 | 4,628 | 322 | 1,947 |
| Protein | Taxonomy | 5-chloromethylfluorescein diacetate (IC50) | thioctic acid (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 2.68 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 2.68 | |
| hexokinase | Trypanosoma brucei brucei TREU927 | 0.2008 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 2.68 | |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | 16.56 | |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | 16.56 | |
| Vif | Human immunodeficiency virus 1 | 7.67 | |
| Tat | Human immunodeficiency virus 1 | 5.891 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 7.67 | |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 3.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reymann, KG; Röhnert, P; Schröder, UH; Striggow, F; Täger, M; Ziabreva, I | 1 |
1 other study(ies) available for 5-chloromethylfluorescein diacetate and thioctic acid
| Article | Year |
|---|---|
Insufficient endogenous redox buffer capacity may underlie neuronal vulnerability to cerebral ischemia and reperfusion.
Topics: Animals; Brain Ischemia; Cell Death; Disease Models, Animal; Ethidium; Fluoresceins; Gerbillinae; Glial Fibrillary Acidic Protein; Glucose; Glycoproteins; Hippocampus; Hypoxia; Lectins; Neurons; Neuroprotective Agents; Organ Culture Techniques; Oxidation-Reduction; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Rhodamines; Sulfhydryl Compounds; Thioctic Acid; Versicans | 2012 |